Description |
Lactacystin, an antibiotic Streptomyces spp. metabolite, is a potent and selective proteasome inhibitor with an IC50 of 4.8 μM for 20S proteasome. Lactacystin also inhibits the lysosomal enzyme cathepsin A[1]. Lactacystin inhibits cell growth and induces neurite outgrowth[2].
|
Target |
IC50: 4.8 μM (proteasome)[1]
|
In Vivo |
Lactacystin (microinjection; 2 µg) induces a Parkinson’s disease-like motor phenotype 5-7 days after injection in young and adult mice[2]. Animal Model: Male C57Bl/6RccHsd mice with 8-9 weeks (young) and 12-14 months (adult) old[2] Dosage: 2 µg Administration: Microinjection Result: Induced a Parkinson’s disease-like motor phenotype 5-7 days after injection in young and adult mice.
|
Density | 1.4±0.1 g/cm3 |
Boiling Point | 714.9±60.0 °C at 760 mmHg |
Flash Point | 386.1±32.9 °C |
Exact Mass | 376.130432 |
PSA | 178.33000 |
LogP | -1.10 |
Vapour Pressure | 0.0±5.2 mmHg at 25°C |
Storage condition | −20°C |